REVIEW
Accepted on 18 Aug 2025
Targeting archetypes of viral-driven cancers with immunotherapy: a perspective on immunogenicity within the tumor microenvironment
doi 10.3389/fimmu.2025.1631258
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Overcoming Resistance to Immune Checkpoint Inhibitors: Mechanisms and Strategies in Cancer Therapy
Overcoming Resistance to Immune Checkpoint Inhibitors: Mechanisms and Strategies in Cancer Therapy
1,195
Total downloads
6,333
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 18 Jul 2025
Case Report: Cadonilimab plus anlotinib with radiotherapy for lung adenocarcinoma with pancreatic metastasis in later-line therapy
doi 10.3389/fimmu.2025.1610710
- 571 views
MINI REVIEW
Published on 21 May 2025
Role of TGFβ-activated cancer-associated fibroblasts in the resistance to checkpoint blockade immunotherapy
doi 10.3389/fonc.2025.1602452
- 1,244 views
REVIEW
Published on 21 Mar 2025
The role of B2M in cancer immunotherapy resistance: function, resistance mechanism, and reversal strategies
doi 10.3389/fimmu.2025.1512509
- 2,831 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: